Why the study?
Does a new enzyme immunoassay using anti-MtCK monoclonal antibodies improve the accuracy of CK-MB activity measurement compared to conventional methods in human serum?
Population
Normal human serum and patient serum samples
Comparison
New enzyme immunoassay using monoclonal… vs Conventional CK-MB immunoinhibition method and…
Design
Other
Authors
Loading...
May refine CK-MB specificity in labs; leaves open need for outcome validation before clinical adoption.
Does a new enzyme immunoassay using anti-MtCK monoclonal antibodies improve the accuracy of CK-MB activity measurement compared to conventional methods in human serum?
A novel enzyme immunoassay using anti-MtCK monoclonal antibodies improves the accuracy of true CK-MB measurement by inhibiting mitochondrial creatine kinase activity.
Hoshino et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: